Tuesday, July 10, 2018 8:48:28 AM
$ISR .70.Looks like that 8$ million offering will be eating like candy.I am sure the FDA aproval is not something small.That is dealing with brain tumors.This is huge news.Institutions are gonna be all over it imo.I got a starter at .70.If the selling gets Aggressive shake people out.Then rebound.I like this line of news: Now that the FDA has issued regulatory clearance for GammaTile, the therapy can be made available in the near future to patients served by hospitals throughout the United States
Recent CATX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/12/2026 04:47:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 08:13:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 08:10:44 PM
- Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2026 Results • GlobeNewswire Inc. • 05/11/2026 08:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:43:03 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:23 PM
- Perspective Therapeutics to Provide Several Upcoming Corporate Updates • GlobeNewswire Inc. • 04/24/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 10:05:00 AM
- Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting • GlobeNewswire Inc. • 04/20/2026 10:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2026 08:10:52 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2026 08:10:05 PM
- Perspective Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/02/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:16:31 PM
- Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 03/17/2026 08:45:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/16/2026 08:12:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:10:36 PM
- Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results • GlobeNewswire Inc. • 03/16/2026 08:07:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/11/2026 12:36:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:38:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:38:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:37:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:37:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:35:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:34:56 PM
